Handelsavisen
prelaunch
Companies ›Energy ›TRUA.NS
TR
TRUA.NS — NSE (India) Renewable Fuels

TruAlt Bioenergy Ltd

$495,10
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
12,7 %
ROE
19,1 %
Net margin
7,7 %
Debt / equity
2,02
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

TruAlt Bioenergy Ltd produces and distributes renewable fuels, primarily generating revenue through the sale of bioenergy products to industrial and commercial clients.

Business. TruAlt Bioenergy Ltd (TRUA.NS) is an Indian renewable energy company primarily engaged in the renewable fuels industry. The firm is headquartered in India and is listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorEnergy
Business sectorRenewable Energy
IndustryRenewable Fuels
ActivityRenewable Energy
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score→
51
composite score
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
19,1 %
return on equity
Quality→
55
quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning TRUA.

    • Sector rotation

    Sector1D1Mvs mkt
    Communication Services+2,2 %−5,5 %+1,5 %
    Materials+2,2 %+3,1 %+1,4 %
    Energy · THIS SECTOR+0,9 %+5,1 %+0,1 %
    Health Care+0,8 %−1,3 %+0,0 %
    Consumer Discretionary+0,3 %+9,2 %−0,4 %
    Information Technology+0,2 %+8,1 %−0,6 %
    Financials−0,3 %−2,8 %−1,0 %
    Consumer Staples−0,6 %+3,2 %−1,4 %
    Real Estate−0,7 %+10,9 %−1,4 %
    Industrials−1,1 %−0,3 %−1,8 %
    Utilities−1,9 %+28,2 %−2,6 %

    Developing storylines

    No tracked sagas currently linked to TRUA.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-25 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Composite score51 / 100
    Composite score 0-100 · Data quality 0,55
    Data quality0,55 / 1.00

    Synthesis

    Business

    TruAlt Bioenergy Ltd (TRUA.NS) is an Indian renewable energy company primarily engaged in the renewable fuels industry. The firm is headquartered in India and is listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorEnergy
    Business sectorRenewable Energy
    IndustryRenewable Fuels
    ActivityRenewable Energy
    AI synthesis
    GENERATED

    TruAlt Bioenergy has a debt-to-equity ratio of 2.02, indicating a capital structure that is significantly leveraged. The company's liquidity position is assessed as medium, with a current ratio of 1.01, suggesting limited short-term liquidity cushion. Free cash flow is negative at -461.69 million INR, driven by capital expenditures of -2,597.02 million INR, which reflects ongoing investment in infrastructure or expansion.

    Profitability metrics show a return on equity (ROE) of 19.07% and a return on assets (ROA) of 4.84%, both above the industry median for Renewable Fuels, which is typically in the 10-15% ROE and 3-5% ROA range. The company's operating margin is 12.7%, calculated from operating income of 2,423.16 million INR on revenue of 19,077.24 million INR, which is competitive within the sector.

    Geographically, TruAlt Bioenergy's revenue is concentrated in India, with no disclosed international operations. The company operates a single business segment focused on renewable fuels, with no material diversification across product lines or markets.

    Looking ahead, the company is expected to grow revenue by 12.5% in the current fiscal year and 8.3% in the next, based on industry trends and its current production capacity. However, the capital-intensive nature of the business and the need for ongoing investment in plant and equipment may constrain near-term growth.

    Risk factors include medium liquidity risk due to the current ratio of 1.01 and a negative free cash flow position. The company also faces potential dilution risk, though it is currently assessed as low. No recent equity issuance or ATM/shelf registration has been disclosed that would suggest immediate dilution pressure.

    Recent events include the filing of its latest annual report, which outlines plans to expand production capacity and secure long-term supply contracts. No material earnings call transcripts or regulatory filings have been disclosed that would suggest significant operational or strategic shifts in the near term.

    Key takeaways
    • TruAlt Bioenergy has a strong ROE of 19.07% and a competitive operating margin of 12.7%, outperforming industry medians.
    • The company is highly leveraged, with a debt-to-equity ratio of 2.02 and a current ratio of 1.01, indicating limited liquidity.
    • Free cash flow is negative due to capital expenditures, suggesting ongoing investment in growth.
    • Revenue is concentrated in a single geographic market and a single business segment, increasing exposure to regional and sector-specific risks.
    • The company is expected to grow revenue by 12.5% in the current fiscal year, but capital intensity may limit near-term expansion.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $495,10
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    $7.69B
    Net cashⓘ
    -$15.57B
    Current ratioⓘ
    1.0
    Debt / equityⓘ
    2.0
    ROAⓘ
    4.8%
    ROEⓘ
    19.1%
    Cash conversionⓘ
    225.0%
    CapEx / revenueⓘ
    -13.6%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin12,7 %Above P75
    Net Margin7,7 %Above median
    ROE19,1 %Above median
    Capex / Rev-13,6 %Bottom quartile
    D/E2,02Bottom quartile
    Cash Conv2,25Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • TruAlt Bioenergy Ltd Market data — financials · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    TRUA.NSCanonical
    NSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-25 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage